In Taiwan, extending a drug’s expiry date requires conducting long-term stability studies on three production batches, ensuring the product maintains safety, efficacy, and quality. The results must align with TFDA guidelines and international standards. Manufacturers must submit these findings for review, with any changes reported promptly to the TFDA for approval.